Management

Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon, remains optimistic about her expectations from the Modi government…

The Uniform Code of Pharmaceutical Marketing Practices (UCPMP), launched by the Department of Pharmaceuticals (DoP) has not roused…

In the aftermath of this year’s USTR Special 301 Report, which retained India on the Priority Watch List, industry leaders comment…

In an exclusive analysis for Express Pharma, Professor Brook K Baker, Northeastern U School of Law, and senior policy analyst,…

Milind Antani, Partner in charge of pharma-life sciences and healthcare practice, Nishith Desai Associates, Ajay Chandru and…

National Pharmaceutical Pricing Authority (NPPA) has allowed pharma companies to increase the prices of 509 essential medicines in…

Sankar Sundaram, Professor of Pharmaceutical Sciences, JSS University, talks about data exclusivity and if effective then how it…

The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated…

Executives in the life sciences industry reveal their key concerns in cross-border acquisitions in pharmerging markets

The company’s latest report states that this growth was marginally slower than during the previous five years